Research On Acne
How does Acne Develop?
 Doctors describe acne as a disease of the pilosebaceous units (PSUs). Found over
most of the body, PSUs consist of a sebaceous gland connected to a canal, called
a follicle, that contains a fine hair (see diagram below). These units are most numerous on the face, upper back, and chest. The
sebaceous glands make an oily substance called sebum that normally empties onto
the skin surface through the opening of the follicle, commonly called a pore.
Cells called keratinocytes line the follicle.
The hair, sebum, and keratinocytes that fill the narrow follicle may produce a
plug, which is an early sign of acne. The plug prevents sebum from reaching the
surface of the skin through a pore. The mixture of oil and cells allows bacteria
Propionibacterium acnes (P. acnes) that normally live on the skin to grow
in the plugged follicles. These bacteria produce chemicals and enzymes and
attract white blood cells that cause inflammation. (Inflammation is a
characteristic reaction of tissues to disease or injury and is marked by four
signs: swelling, redness, heat, and pain.) When the wall of the plugged follicle
breaks down, it spills everything into the nearby skin--sebum, shed skin cells,
and bacteria--leading to lesions or pimples.
Medical researchers are working on new drugs to treat acne,
particularly topical antibiotics to replace some of those in current use. As
with many other types of bacterial infections, doctors are finding that, over
time, the bacteria that are associated with acne are becoming resistant to
treatment with certain antibiotics. Research is also being conducted by industry
on the potential side effects of isotretinoin and the long-term use of medicines
used for treating acne.
Scientists are working on other means of treating acne. For
example, researchers are studying the biology of sebaceous cells and testing a
laser in laboratory animals to treat acne by disrupting sebaceous glands.
Scientists are also studying the treatment of androgenic disorders, including
acne, in men by inhibiting an enzyme that changes testosterone to a more potent
androgen.
|
|
|